| Source: |
| Type: |
| Various antioxidants such as Nrf2, SODs, catalase, GPxs, PRDXs, and GSTs are altered in different cancers and have been linked to prognosis. Their overexpression can correlate with aggressive tumor behavior and resistance to treatment in many contexts. |
| 6906- | FIS, | Rad, | Combining fisetin and ionizing radiation suppresses the growth of mammalian colorectal cancers in xenograft tumor models |
| - | in-vivo, | CRC, | CT26 | - | in-vivo, | CRC, | HCT116 |
| 6897- | FIS, | Fisetin: A Dietary Antioxidant for Health Promotion |
| - | Review, | Nor, | NA |
| 6922- | FIS, | Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin |
| - | Review, | Var, | NA |
| 5392- | FIS, | AsP, | Fisetin topical delivery via ascorbyl palmitate/hyaluronan-enhanced limosomes: a novel paradigm for preventing UVB-induced skin photoaging |
| - | in-vivo, | Nor, | NA |
| 2313- | Flav, | Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism |
| - | Review, | Var, | NA |
| 6925- | Flav, | Important Flavonoids and Their Role as a Therapeutic Agent |
| - | Review, | Nor, | NA |
| 6924- | Flav, | Plant Flavonoids: Chemical Characteristics and Biological Activity |
| - | Review, | Nor, | NA |
| 6923- | Flav, | Flavonoids: an overview |
| - | Review, | Nor, | NA |
| 7012- | Fuc, | Fucoidan: A promising natural therapeutic agent for protecting human kidney health |
| - | Review, | EC, | NA |
| 7013- | Fuc, | Fucoidan-based nanoparticles for colorectal cancer therapy: Mechanisms and preclinical insights |
| - | Review, | CRC, | NA |
| 7018- | Fuc, | Absorption Study of Mozuku Fucoidan in Japanese Volunteers |
| - | Trial, | Nor, | NA |
| 7019- | Fuc, | Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43 |
| - | vitro+vivo, | HCC, | HUH7 |
| 7006- | Fuc, | Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug—A Review |
| - | Review, | Var, | NA |
| 7007- | Fuc, | The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles |
| - | Review, | Var, | NA |
| 7008- | Fuc, | Ten Years of Research on Fucoidan and Cancer: Focus on Its Antiangiogenic and Antimetastatic Effects |
| - | Review, | Var, | NA |
| 4024- | FulvicA, | ANTI-CARCINOGENIC ACTIVITY OF SHILAJIT REGARDING TO APOPTOSIS ASSAY IN CANCER CELLS: A SYSTEMATIC REVIEW OF IN-VITRO STUDIES |
| - | Review, | Var, | NA |
| 4025- | FulvicA, | Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment |
| - | in-vitro, | Bladder, | T24/HTB-9 | - | Review, | AD, | NA |
| 4026- | FulvicA, | Shilajitin Cancer Treatment: Probable Mode of Action |
| - | Review, | Var, | NA |
| 4016- | FulvicA, | Shilajit: A Natural Phytocomplex with Potential Procognitive Activity |
| - | Review, | AD, | NA |
| 7035- | GA, | Gallic acid attenuates LPS-induced inflammation in Caco-2 cells by suppressing the activation of the NF-κB/MAPK signaling pathway |
| - | in-vitro, | IBD, | Caco-2 |
| 7042- | GA, | Gallic acid reduces cell growth by induction of apoptosis and reduction of IL-8 in HepG2 cells |
| - | in-vitro, | Liver, | HepG2 |
| 7049- | GA, | Pharmacological effects of gallic acid in health and diseases: A mechanistic review |
| - | Review, | Var, | NA |
| 1773- | GA, | Impact of Gallic Acid on Gut Health: Focus on the Gut Microbiome, Immune Response, and Mechanisms of Action |
| - | Review, | Var, | NA |
| 7069- | GABA, | United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA) |
| - | Review, | Nor, | NA |
| 7066- | GamB, | Unravelling the Therapeutic Potential of Gambogic Acid: Deciphering Its Molecular Mechanism of Action and Emerging Role as an Anticancer Xanthone |
| - | Review, | Var, | NA |
| - | in-vivo, | Nor, | NA |
| 7090- | GAR, | Garcinol |
| 7091- | GAR, | Garcinol-A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug |
| - | Review, | Var, | NA |
| 7092- | GAR, | Garcinol and Its Role in Chronic Diseases |
| - | Review, | Var, | NA |
| 7234- | GBE, | Ginkgo Biloba Extract Ameliorates Oxidative Phosphorylation Performance and Rescues Aβ-Induced Failure |
| - | in-vitro, | Nor, | NA |
| 7205- | GBE, | Exploring the multifaceted role of ginkgolides and bilobalide from Ginkgo biloba in mitigating metabolic disorders |
| - | Review, | AD, | NA |
| 7206- | GBE, | EGb 761, | Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review |
| - | Review, | AD, | NA |
| 7212- | GBE, | The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 1189- | GBE, | New insight into the mechanisms of Ginkgo biloba leaves in the treatment of cancer |
| - | Review, | NA, | NA |
| 3723- | GBE, | Can We Use Ginkgo biloba Extract to Treat Alzheimer’s Disease? Lessons from Preclinical and Clinical Studies |
| - | Review, | AD, | NA |
| 7133- | Ge-132, | Organogermanium, Ge-132, promotes the clearance of senescent red blood cells via macrophage-mediated phagocyte activation |
| - | in-vitro, | Nor, | RAW264.7 |
| 7103- | GEN, | A Comprehensive Review of Genistein's Effects in Preclinical Models of Cervical Cancer |
| - | Review, | Cerv, | NA |
| 7102- | GEN, | Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits |
| - | Review, | Var, | NA |
| 6562- | Ger, | Potential Effects of Geraniol on Cancer and Inflammation-Related Diseases: A Review of the Recent Research Findings |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6567- | Ger, | Geraniin inhibits proliferation and induces apoptosis through inhibition of phosphatidylinositol 3-kinase/Akt pathway in human colorectal cancer in vitro and in vivo |
| - | vitro+vivo, | CRC, | SW480 | - | in-vitro, | CRC, | HT29 |
| 6571- | Ger, | Unlocking the therapeutic potential of Geraniol: an alternative perspective for metabolic disease management |
| - | Review, | Obesity, | NA |
| 7217- | GGB, | Role of Ginkgolides in the Inflammatory Immune Response of Neurological Diseases: A Review of Current Literatures |
| - | Review, | AD, | NA |
| 7141- | GI, | Synthesis of New Shogaol Analogues as NRF2 Activators and Evaluation of Their Anti-Inflammatory Activity, Modes of Action and Metabolic Stability |
| - | Study, | Nor, | BV2 |
| 7142- | GI, | Phase II study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer |
| - | Trial, | Nor, | NA |
| 7140- | GI, | Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes |
| - | Review, | Var, | NA |
| 7135- | GI, | Examination of the Pharmacokinetics of Active Ingredients of Ginger in Humans |
| - | Trial, | Nor, | NA |
| 6771- | GI, | A glimpse on influences of ginger and its derivatives as a feed additive in finfish farming: A mini-review |
| - | Review, | Nor, | NA |
| 4247- | GI, | 6-Shogaol from Dried Ginger Protects against Intestinal Ischemia/Reperfusion by Inhibiting Cell Apoptosis via the BDNF/TrkB/PI3K/AKT Pathway |
| - | vitro+vivo, | NA, | NA |
| 2464- | GI, | The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review |
| - | Review, | Nor, | NA |
| 7251- | Gink, | Ginkgetin: A Promising Multitarget Agent for Diverse Diseases |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1103 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid